Work Underway To Demystify Why Regulators Respond Differently To Drug Safety Issues

 
• By Vibha Sharma

An independent UK-based pharmacovigilance unit has begun exploring and analyzing why national regulatory authorities across the globe respond differently to the same post-marketing concerns. 

American healthcare, conceptual image.
Thresholds for taking regulatory action and decisions can vary • Source: Alamy

More from United Kingdom

More from Europe